Munich Leukemia Laboratory: Utilizing NGS for new insights into leukemia and lymphoma

October 28, 2017

Dr Torsten Haferlach of Munich Leukemia Laboratory (MLL) discusses their goal to sequence, by whole genome sequencing, 5,000 patients with different kinds of leukemias and lymphomas—ultimately understanding the baseline of the disease. Hear how they’re utilizing the flow cells and scalability of the NovaSeq™ 6000 System to expand their research further than before.

View related videos

View related webinars

View related information

Subscribe to the Illumina video channel

For Research Use Only. Not for use in diagnostic procedures.

Share this article on